Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.58
Delayed Data
As of 4:02pm ET
 -0.12 / -0.19%
Today’s Change
53.06
Today|||52-Week Range
66.80
+6.30%
Year-to-Date
What Happened The Last Time Companies Got A Tax-Break On Overseas Cash?
8:04pm / Investing Channel - Paid Partner Content
What's in Store for Merck (MRK) this Earnings Season?
Apr 26 / Zacks.com - Paid Partner Content
Agran Libbie Buys 3M Co, Douglas Emmett, Alerian MLP, Sells Martin Midstream Partners...
3:40pm / GuruFocus News - Paid Partner Content
Surveying the NASH Liver-Disease Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
Bristol-Myers (BMY) Beats on Q1 Earnings, Ups 2017 View
11:35am / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?
Apr 25 / Zacks.com - Paid Partner Content
Breton Hill Capital Ltd. Buys Philip Morris International, Pfizer, Reynolds American,...
Apr 26 / GuruFocus News - Paid Partner Content
3 IPOs to Watch For This Week
Apr 24 / Zacks.com - Paid Partner Content
Surveying the NASH Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Apr 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close62.70
Today’s open62.78
Day’s range62.45 - 62.91
Volume6,603,329
Average volume (3 months)10,015,302
Market cap$171.9B
Dividend yield3.00%
Data as of 4:02pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+0.62%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+1.86%
P/E ratio44.4
Price/Sales4.15
Price/Book4.30

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.71+0.93%
PFEPfizer+0.01+0.03%
SNYSanofi+0.49+1.06%
ABBVAbbVie+1.03+1.58%
Data as of 4:02pm ET, 04/27/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts